Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
Appointed director
CC transcript
Asset disposition
Inv. presentation
Director departure
HOLOGIC INC (HOLX) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/27/2022 8-K Quarterly results
Docs: "Hologic Announces Financial Results for Third Quarter of Fiscal 2022 – Revenue of $1.003 Billion, GAAP Diluted EPS of $0.90, and Non-GAAP Diluted EPS of $0.95 All Significantly Ahead of Expectations – – Global Organic Molecular Diagnostics ex-COVID-19 Revenue Grows Over 20% in Constant Currency – – Company Again Increases Full-Year Revenue and EPS Guidance –"
04/27/2022 8-K Quarterly results
Docs: "Hologic Announces Financial Results for Second Quarter of Fiscal 2022 – Revenue of $1.436 Billion, GAAP Diluted EPS of $1.80, and Non-GAAP Diluted EPS of $2.07 All Significantly Ahead of Expectations – – Company Again Increases Full-Year Revenue and EPS Guidance –"
02/02/2022 8-K Quarterly results
11/01/2021 8-K Quarterly results
Docs: "Hologic Announces Financial Results for Fourth Quarter of Fiscal 2021 – Revenue of $1.317 Billion Exceeds Expectations – – Company Posts GAAP Diluted EPS of $1.28, Non-GAAP Diluted EPS of $1.61 – – Financial Guidance for Fiscal 2022 Anticipates Solid Growth in Core Women’s Health Businesses and Continued Contributions to COVID-19 Fight –"
07/28/2021 8-K Quarterly results
Docs: "Hologic Announces Financial Results for Third Quarter of Fiscal 2021 — Revenue of $1.168 Billion Increases 42.0%, 37.8% in Constant Currency — — Organic Revenue Increases 38.4%, 34.2% in Constant Currency — — Company Posts GAAP Diluted EPS of $1.04, Non-GAAP Diluted EPS of $1.33"
01/27/2021 8-K Quarterly results
Docs: "Hologic Announces Financial Results for First Quarter of Fiscal 2021 – Revenue of $1.61 Billion Increases 89.3%, 86.5% in Constant Currency – – Organic Revenue Increases 107.0%, 104.0% in Constant Currency – – Company Posts GAAP Diluted EPS of $2.50, Non-GAAP Diluted EPS of $2.86 –"
11/04/2020 8-K Quarterly results
Docs: "Hologic Announces Financial Results for Fourth Quarter of Fiscal 2020 — Revenue of $1.347 Billion Increases 55.6%, 54.2% in Constant Currency — — Organic Revenue Increases 72.5%, 70.9% in Constant Currency, as Strong Sales of COVID Tests Offset Declines in Other Businesses — — Company Posts GAAP Diluted EPS of $1.88, Non-GAAP Diluted EPS of $2.07"
07/29/2020 8-K Quarterly results
04/29/2020 8-K Quarterly results
Docs: "Hologic Announces Financial Results for Second Quarter of Fiscal 2020 – Revenue of $756.1 Million Declines 7.6% due to Cynosure Divestiture, 7.1% in Constant Currency – – Organic Revenue Increases 0.5%, 1.1% in Constant Currency – – Company Posts GAAP Diluted EPS of $0.36, Non-GAAP Diluted EPS of $0.57 – – Company to Introduce Second High-Throughput Coronavirus Test for Panther® Platform –",
"Hologic to Introduce Its Second High-Throughput Molecular Assay for the Novel Coronavirus"
01/29/2020 8-K Quarterly results
Docs: "Hologic Announces Financial Results for First Quarter of Fiscal 2020 – Revenue of $850.5 Million Grows 2.4%, 2.8% in Constant Currency – – Excluding Acquisitions and Divestitures, Revenue Increases 4.1%, 4.6% in Constant Currency – – Company Posts GAAP Diluted EPS of $1.43 Due to One-Time Tax Benefit, Non-GAAP Diluted EPS of $0.61 – – Following Cynosure Divestiture, Company Expects Faster Revenue Growth, Higher EPS –"
11/06/2019 8-K Quarterly results
Docs: "Hologic Announces Financial Results for Fourth Quarter of Fiscal 2019 – Revenue of $865.8 Million Grows 6.4%, 7.3% in Constant Currency – – Company Posts GAAP Diluted EPS of $0.15 Due to Non-Cash Charges, Non-GAAP Diluted EPS of $0.65 – – Company Expects Solid Revenue and Non-GAAP EPS Growth in Fiscal 2020 –"
07/31/2019 8-K Quarterly results
Docs: "Hologic Announces Financial Results for Third Quarter of Fiscal 2019 – Revenue of $852.4 Million Grows 3.4%, 4.7% in Constant Currency – – Company Posts GAAP Diluted EPS of $0.35, Non-GAAP Diluted EPS of $0.63 –"
05/01/2019 8-K Quarterly results
Docs: "Hologic Announces Financial Results for Second Quarter of Fiscal 2019 – Revenue of $818.4 Million Grows 3.7%, 5.2% in Constant Currency – – Company Posts GAAP Loss per Share of Due to Non-Cash Charges, Non-GAAP Diluted Earnings per Share of $0.58 – – Company Raises Full-Year Guidance for Revenue and Non-GAAP EPS –"
01/30/2019 8-K Quarterly results
11/07/2018 8-K Quarterly results
Docs: "Hologic Announces Financial Results for Fourth Quarter of Fiscal 2018 – Revenue of $813.5 Million Grows 1.3%, 1.7% in Constant Currency – – Company Posts GAAP Diluted EPS of $0.18, Non-GAAP Diluted EPS of $0.58 – – Company Expects Solid Revenue and EPS Growth in Fiscal 2019 –"
07/31/2018 8-K Quarterly results
Docs: "Hologic Announces Financial Results for Third Quarter of Fiscal 2018"
05/02/2018 8-K Quarterly results
Docs: "Hologic Announces Financial Results for Second Quarter of Fiscal 2018"
02/08/2018 8-K Quarterly results
Docs: "Hologic Announces Financial Results for First Quarter of Fiscal 2018"
11/08/2017 8-K Quarterly results
Docs: "Hologic Announces Financial Results for Fourth Quarter of Fiscal 2017"
08/02/2017 8-K Quarterly results
Docs: "Hologic Announces Financial Results for Third Quarter of Fiscal 2017"
05/10/2017 8-K Form 8-K - Current report
02/01/2017 8-K Form 8-K - Current report
11/02/2016 8-K Form 8-K - Current report
07/27/2016 8-K Form 8-K - Current report
04/27/2016 8-K Form 8-K - Current report
01/27/2016 8-K Quarterly results
Docs: "Hologic Announces Financial Results for First Quarter of Fiscal 2016"
11/04/2015 8-K Quarterly results
Docs: "Exhibit 99.1 Hologic Announces Financial Results for Fourth Quarter of Fiscal 2015"
07/29/2015 8-K Quarterly results
Docs: "Exhibit 99.1 Hologic Announces Financial Results for Third Quarter of Fiscal 2015"
04/29/2015 8-K Quarterly results
Docs: "Hologic Announces Financial Results for Second Quarter Fiscal 2015"
01/28/2015 8-K Quarterly results
Docs: "Hologic Announces Financial Results for First Quarter Fiscal 2015"
11/05/2014 8-K Quarterly results
Docs: "Form of Annual Stock Option Award Agreement (adopted fiscal 2015)",
"Form of Performance Stock Unit Award Agreement (adopted fiscal 2015)",
"Hologic Announces Fourth Quarter Fiscal 2014 Operating Results"
07/30/2014 8-K Quarterly results
Docs: "Hologic Announces Third Quarter Fiscal 2014 Operating Results"
04/30/2014 8-K Quarterly results
Docs: "Senior Director, Investor Relations"
02/03/2014 8-K Quarterly results
Docs: "Senior Director, Investor Relations"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy